Precision Medicine is used for treating and preventing diseases by considering the individual variability in genes, environment, and lifestyle of each person. This approach allows doctors and researchers to predict more accurately which treatment and prevention strategies are suitable for a particular disease and for which groups of people.

DeepTech Talk Podcast by BIS Research

We, at BIS Research, have started a weekly Podcast to provide market updates. In the first episode, we have covered precision medicine in-depth and you can listen to it on Spotify and Amazon music.

Investment Activities

1. Sema4 has signaled its intent to grow into a juggernaut of precision medicine by going public. The company has raised about $500 million through a business combination completed with CM Life Sciences. [source]
2. Artios announces $153 Million (£110 Million) Series C financing led by Omega Funds and TCG X, to develop a diverse pipeline of product candidates for the treatment of cancer. [source]
3. Caris Life Sciences raises $830 Million in growth equity capital to continue to expand its precision medicine platform. [source]

New Product Launches

1.  AdventHealth and Sema4 launch a data-driven precision medicine program to optimize patient care and outcomes. [source]
2. Parisian biotech Advicenne (Euronext: ADVIC) has provided a business update, highlighting a recent positive scientific opinion for lead medicine ADV7103 (potassium citrate/potassium hydrogen carbonate) in Europe. [source]
3. Dalrada Financial Corporation Enters Genomics Market, Launches Empower Genomics Subsidiary of Dalrada Health. [source]

Government Regulation Updates

1. The Morrison Government is investing $180 million in ground-breaking medical research projects around Australia to improve the lives of Australians and their loved ones. [source]
2. Phase II of Singapore's National Precision Medicine strategy to begin in April 2021 with an aim to Further research insights into the Asian phenotype by analyzing the genetic makeup. [source]

Related Technologies

1.  Based on BIS analysis, the global market for regenerative medicines is predicted to grow at a CAGR of 13.99% over the forecast period of 2020-2030. [source]
2. Our healthcare experts have found long-read sequencing to be one of the most rapidly evolving technologies, and the global market is predicted to grow at a CAGR of 21.15% over the forecast period of 2021-2030. [source]

BIS Research Updates in the Precision Medicine Space -

1. Analyst Note - Implications of COVID-19 on Life Sciences Industry
2. Messenger Ribonucleic Acid (mRNA) Technology enables Development of Vaccines for Life-Threatening Infectious Diseases
3. Precision Psychiatry Tests Help in Identifying Protein and Genetic Alterations Causing Psychotic Conditions
4. Long-Read Sequencing – The Emergence of Third-Generation Sequencing

For updates on emerging technology markets in your industry/area of interest, subscribe to our newsletter and stay ahead on the latest tech trends.

Looking to evaluate the market potential of your world-changing idea?

Need research on an ongoing basis?

Please feel free to reach out at ahmad.shaquib@bisresearch.com in case of any doubt or query.